The Korean Journal of Urological Oncology 2011;9(3):124-129.
Published online December 30, 2011.
전립선비대증 환자의 수술적 치료에서 경요도 양극성 플라즈마 전립선기화술의 초기경험
이용택, 이동민, 류영우, 임송원, 염승희, 한준현
한국전력의료재단 한일병원 비뇨기과
Initial Experiences with Transurethral Bipolar Plasma Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia
Yong Taec Lee , Dong Min Lee , Young Woo Ryu , Song Won Lim , Seung Hee Yum , June Hyun Han
Department of Urology, Korea Electric Power Corporation Medical Foundation, Han-il General Hospital, Seoul, Korea
Correspondence:  June Hyun Han
Abstract
Purpose
This study was conducted to introduce the initial experiences with transurethral bipolar plasma vaporization of the prostate (TBPVP) using 'mushroom' vapo-resection electrode for the treatment of benign prostatic hyperplasia (BPH) in Korean men. Materials and Methods: We retrospectively analysed the clinical data of 42 consecutive patients underwent TBPVP performed by a single surgeon between October 2009 and April 2011. The patients were assessed preoperatively and perioperatively, and were followed at 2, 4, and 8 weeks postoperatively. Patient baseline characteristics, perioperative data, postoperative outcomes, and major complications were recorded. Results: The mean age at surgery was 70.93±6.26 years. The mean prostate size was 64.10±17.83ml. The mean operation time was 59.40±25.99min, and the mean irrigation fluid volume during procedure was 26,000±10,511ml. The mean duration of catheterization was 3.57±0.94 days. The blood loss was minimal, and there was only 1 transfusion for the patient with ongoing heparization. Compared with baseline, there were significant improvements in IPSS, QoL, Qmax and postvoiding residual urine after surgery. Conclusions: The new TBPVP showed good short-term safety and efficacy for the treatment of Korean patients with BPH. (Korean J Urol Oncol 2011;9:124-129)
Key Words: Prostatic hyperplasia, Transurethral resection of prostate, Ablation techniques


Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI